Search

Your search keyword '"Merck Sharp & Dohme Corp. -- Intellectual property"' showing total 70 results

Search Constraints

Start Over You searched for: Descriptor "Merck Sharp & Dohme Corp. -- Intellectual property" Remove constraint Descriptor: "Merck Sharp & Dohme Corp. -- Intellectual property" Topic biological sciences Remove constraint Topic: biological sciences
70 results on '"Merck Sharp & Dohme Corp. -- Intellectual property"'

Search Results

2. 'Hydroxypyrrolidine-Substituted Arylsulfonamide Compounds With Selective Activity In Voltage-Gated Sodium Channels' in Patent Application Approval Process (USPTO 20220305035)

3. 'Enzymatic Synthesis Of 4'-Ethynyl Nucleoside Analogs' in Patent Application Approval Process (USPTO 20220228184)

4. 'Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors For The Treatment Or Prevention Of Diabetes' in Patent Application Approval Process (USPTO 20200206221)

5. 'Process Of Making And Using Pharmaceutical Formulations Of Antineoplastic Agents' in Patent Application Approval Process (USPTO 20190336495)

6. Patent Issued for Modulation Of Tumor Immunity (USPTO 10,188,729)

7. Patent Issued for Prefilled Disposable Injection Device (USPTO 10,155,088)

9. Patent Issued for Amidoethyl Azole Orexin Receptor Antagonists (USPTO 10,155,750)

12. 'Novel Processes For Making Substituted Quinazoline Compounds Using Hydrogen Bonding Catalysts' in Patent Application Approval Process (USPTO 20180346429)

13. Patent Issued for Process For Preparing Substituted Indole Compounds (USPTO 10,131,674)

14. Patent Application Titled 'Metering Injector For Deliverng Liquid, And Method Of Using Same' Published Online (USPTO 20180326157)

15. Patent Issued for CRZ1 Mutant Fungal Cells (USPTO 10,100,343)

16. Patent Issued for Process For Making Beta 3 Agonists And Intermediates (USPTO 10,087,189)

17. Patent Issued for Formulation Inhibiting Effects Of Low Acid Environment (USPTO 10,085,991)

18. Patent Application Titled 'Crystal Forms Of A M1 Receptor Positive Allosteric Modulator' Published Online (USPTO 20180273507)

19. Patent Application Titled '7-Aminocephem Derivative Compounds' Published Online (USPTO 20180258101)

20. Researchers Submit Patent Application, 'Pegylated Interleukin-10', for Approval (USPTO 20180250363)

21. 'Forms Of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)pyridin-5-Yl)-3-Fluorophenyl)-5- -Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate' in Patent Application Approval Process (USPTO 20180251482)

22. Patent Issued for Forms Of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)pyridin-5-Yl)-3-Fluorophenyl)-5- -Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate (USPTO 10,065,947)

23. 'Forms Of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)pyridin-5-Yl)-3-Fluorophenyl)-5- -Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate' in Patent Application Approval Process (USPTO 20180244704)

24. Researchers Submit Patent Application, 'Assay For Simultaneous Genomic And Proteomic Analysis', for Approval (USPTO 20180208975)

25. Patent Issued for Pyrazolyl Carboxylic Acid And Pyrazolyl Urea Derivative Compounds (USPTO 10,035,774)

26. Patent Issued for Methods For Treating Intrapulmonary Infections (USPTO 10,028,963)

27. Patent Issued for Polymeric Nanoparticles and Methods of Making and Using Same (USPTO 10022360)

28. Patent Issued for Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)pyridin-5-Yl)-3-Fluorophenyl)-5- -Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate (USPTO 9988406)

29. Patent Issued for 2-Pyridyloxy-3-Ester-4-Ether Orexin Receptor Antagonists (USPTO 9975876)

30. Patent Issued for Pharmaceutical Salts of an Orexin Receptor Antagonist (USPTO 9969725)

31. Patent Issued for Pegylated Interleukin-10 (USPTO 9925245)

32. Patent Issued for Method for Treating Cancer (USPTO 9925192)

33. Patent Issued for TrkA Kinase Inhibitors, Compositions and Methods (USPTO 9896447)

34. Patent Issued for Surface Anchored Light Chain Bait Antibody Display System (USPTO 9890378)

35. Patent Issued for Process for Making Substituted Quinazoline Compounds (USPTO 9890128)

36. Patent Issued for Tetrahydroisoquinoline Derivatives Useful as Inhibitors of Diacylglyceride O-Acyltransferase 2 (USPTO 9877957)

37. Patent Issued for Dual Chamber Mixing Syringes and Methods of Using Same (USPTO 9872962)

38. Patent Issued for Dengue Virus Vaccine Compositions and Methods of Use (USPTO 9861692)

39. 'Expression Vectors for Recombinant Protein Production in Mammalian Cells' in Patent Application Approval Process (USPTO 20160194660)

40. Researchers Submit Patent Application, 'On-Column Refolding and Purifying of Lipoproteins', for Approval (USPTO 20150307591)

41. Patent Issued for 2,5-Disubstituted Thiomorpholine Orexin Receptor Antagonists

42. Patent Issued for Piperidinyl Alkyne Orexin Receptor Antagonists

43. Patent Issued for Pyrrolidine Derived .Beta.3 Adrenergic Receptor Agonists

44. Patent Issued for Cyclobutyl Sulfones as Notch Sparing Gamma Secretase Inhibitors

45. Patent Issued for 2,5-Disubstituted Piperidine Orexin Receptor Antagonists

46. Researchers Submit Patent Application, 'Methods for Modulating Il-33 Activity', for Approval

47. Patent Issued for Pyridazine Carboxamide Orexin Receptor Antagonists

48. Patent Issued for Single Chemical Entities and Methods for Delivery of Oligonucleotides

49. Patent Issued for Diazepan Orexin Receptor Antagonists

50. Patent Issued for 2,5-Disubstituted Piperidine Orexin Receptor Antagonists

Catalog

Books, media, physical & digital resources